- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Molecular Imaging Technology for DiagnosticsTypical Imaging TechniquesX-Ray Computed Tomography (X-CT);Magnetic Resonance Imaging (MRI);Positron Emission Tomography (PET);Single-Photon Emission Computed Tomography (SPECT);Optical Imaging (OI);Ultrasound image (US);……Molecular imaging in drug developmentNature Reviews Drug Development, 2008, 7, 591However, how to judge efficiently which one isthe most promising candidate for new drug?The key issues for drug development药物研发的关键问题?The activity, targeting ability and the pharmacokinetics of drug药物的活性,靶向,药物代谢等Indeed, the estimated costs of bringing a new potential drug to the end of Phase IIItrials increased approximately 2.5-fold between 1991 and 2001, from US$318 million to $802 million. Assuming a similar cost growth rate, the costs for a new approved drug in 2013 would be $1.9 billion.Molecular imaging is a key method.Abstract | Molecular imaging can allow the non-invasive assessment of biological and biochemical processes in living subjects. Such technologies therefore have the potential to enhance our understanding of disease and drug activity during preclinical and clinical drug development, which could aid decisions to select candidates that seem most likely to be successful or to halt the development of drugs that seem likely to ultimately fail. Here, with an emphasis on oncology, we review the applications of molecular imaging in drug development, highlighting successes and identifying key challenges that need to be addressed for successful integration of molecular imaging into the drug development process.Molecular imaging in drug developmentNature Reviews Drug Development, 2008, 7, 591药物研发的关键问题?药物的活性,靶向,药物代谢等Indeed, the estimated costs of bringing a new potential drug to the end of Phase III trials increased approximately 2.5-fold between 1991 and 2001, from US$318 million to $802 million. Assuming a similar cost growth rate, the costs for a new approved drug in 2013 would be $1.9 billion.X-
您可能关注的文档
最近下载
- 陶瓷行业高端产品市场消费群体细分分析及2025年发展报告.docx
- PMB石油化工项目管理手册 第2部分 项目协调管理程序.doc VIP
- SY_T 6968-2021CN 油气输送管道工程水平定向钻穿越设计规范.docx
- 智慧供应链图谱.pdf VIP
- Starter Units 1-3 检测(含答案) (2024年)人教版英语七年级上册.docx VIP
- 微生物基础知识培训(常用微生物知识).ppt VIP
- 电热食品加工设备食品相关产品生产许可证实施细则2024版.pdf VIP
- 在做好国庆节前后安全生产工作部署会上的讲话.docx
- 特殊作业(动火)监护人培训考核试题答案.docx VIP
- 《大卫·科波菲尔》优秀.ppt VIP
文档评论(0)